InvestorsHub Logo
Followers 65
Posts 2378
Boards Moderated 0
Alias Born 01/16/2011

Re: None

Monday, 08/24/2020 12:49:34 PM

Monday, August 24, 2020 12:49:34 PM

Post# of 64413
Immunity might last only a few months?

TSOI: QuadraMune!

https://www.nytimes.com/2020/08/24/world/covid-19-coronavirus.html?action=click&module=Top%20Stories&pgtype=Homepage
First Confirmed Case of Virus Reinfection Found in Hong Kong
> Researchers said a “young and healthy” patient had a second case more than four months after the first, suggesting immunity might last only a few months.

TSOI: Current clinical trial aims to assess in a 500 volunteer trial the efficacy of QuadraMune in reducing infection in individuals at high risk of COVID-19. [ClinicalTrials.gov Identifier: NCT04421391]; that is, to assess statistically significant increases in immune response activity within 5 days.

IF QuadraMune can increase immune response to the degree that it neutralizes the COVID-19 virus naturally, the mind reels with the possibilities.

IF QM is given in conjunction with a vaccine, could it, would it extend the efficacy of the vaccine?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News